Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Exchange Rate Effect (2019 - 2025)

Apyx Medical (APYX) has disclosed Exchange Rate Effect for 7 consecutive years, with -$75000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Exchange Rate Effect fell 150.0% year-over-year to -$75000.0, compared with a TTM value of -$466000.0 through Dec 2025, down 512.39%, and an annual FY2025 reading of -$466000.0, down 512.39% over the prior year.
  • Exchange Rate Effect was -$75000.0 for Q4 2025 at Apyx Medical, up from -$156000.0 in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $191000.0 in Q3 2022 and bottomed at -$237000.0 in Q2 2025.
  • Average Exchange Rate Effect over 5 years is -$2300.0, with a median of $5500.0 recorded in 2021.
  • The sharpest move saw Exchange Rate Effect skyrocketed 1011.11% in 2022, then tumbled 1347.37% in 2025.
  • Year by year, Exchange Rate Effect stood at $129000.0 in 2021, then plummeted by 68.22% to $41000.0 in 2022, then plummeted by 151.22% to -$21000.0 in 2023, then skyrocketed by 814.29% to $150000.0 in 2024, then plummeted by 150.0% to -$75000.0 in 2025.
  • Business Quant data shows Exchange Rate Effect for APYX at -$75000.0 in Q4 2025, -$156000.0 in Q3 2025, and -$237000.0 in Q2 2025.